Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing...
13 insider purchases on record · latest filing 2025-03-17.
Insiders have also filed 11 sale transactions at CRBU.